SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: I. Luttichuys who wrote (460)3/10/1997 3:01:00 AM
From: Webhead   of 1762
 
While searching for IDEC's "official" annual report on Edgar I came accross this 13D/A listing SmithKlein's stock sales. It's too late for me to look up how much stock SBH used to have to know if the amount reported to the SEC is pre- or post-sale. Irregardless, they've been pretty active selling some 885,000 shares over the month of February (though only 835,000 are accounted for here). Is it known if SBH is done selling or how much is left to go? At these prices, they must really be kicking themselves for selling so soon!

----------------------------------------------------------------------

<PAGE> 3
SCHEDULE 13D

CUSIP NO. 0004493701 Page 3 of 6 Pages

- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

SmithKline Beecham Corporation
23-1099050
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) /x/
(b) / /
- --------------------------------------------------------------------------------
3 SEC USE ONLY

- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*

WC
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(D) OR 2(E) / /

- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION

Pennsylvania

- --------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
SHARES 1,105,860
BENEFICIALLY -----------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH
REPORTING None
PERSON -----------------------------------------------------------------
WITH 9 SOLE DISPOSITIVE POWER

1,105,860
-----------------------------------------------------------------
10 SHARED DISPOSITIVE POWER

None
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

1,105,860
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* / /

- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

6.1%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*

CO
- --------------------------------------------------------------------------------
<PAGE> 4


Page 4 of 6 Pages

Item 1. Security and Issuer.

Item 2. Identity and Background.


Item 3. Source and Amount of Funds or Other Consideration.

Item 4. Purpose of Transaction.
<PAGE> 5
Page 5 of 6 Pages

Item 5. Interest in Securities of the Issuer.

(a) Amount and Percent Beneficially Owned

Registered Name No. of Shares Percent

SmithKline Beecham plc -0- 0%
SmithKline Beecham Corporation 1,105,860 6.1%
_______

TOTAL 6.1%


(b)

(c) The reporting persons sold 885,000 shares of Common Stock
in the open market in the following manner:

<TABLE>
<CAPTION>
Registered Name Transaction Date Number of Share Price Per Share
<S> <C> <C> <C>
SmithKline Beecham plc February 5, 1997 70,000 $22.50
SmithKline Beecham plc February 13, 1997 15,000 $22.25
SmithKline Beecham plc February 14, 1997 7,500 $22.375
SmithKline Beecham plc February 14, 1997 10,000 $22.50
SmithKline Beecham plc February 18, 1997 2,500 $22.375
SmithKline Beecham plc Feburary 20, 1997 2,000 $22.25
SmithKline Beecham plc February 21, 1997 60,000 $22.50
SmithKline Beecham plc February 21, 1997 150,000 $22.575
SmithKline Beecham plc February 21, 1997 100,000 $22.625
SmithKline Beecham plc February 21, 1997 145,000 $22.75
SmithKline Beecham plc February 21, 1997 38,000 $22.875
_______
600,000

SmithKline Beecham Corporation February 21, 1997 5,000 $23.00
SmithKline Beecham Corporation February 24, 1997 50,000 $23.25
SmithKline Beecham Corporation February 24, 1997 145,000 $23.625
SmithKline Beecham Corporation February 24, 1997 50,000 $24.00
SmithKline Beecham Corporation February 24, 1997 6,000 $24.25
SmithKline Beecham Corporation February 25, 1997 29,000 $24.50
SmithKline Beecham Corporation February 28, 1997 17,500 $24.50
SmithKline Beecham Corporation February 28, 1997 25,000 $24.625
SmithKline Beecham Corporation February 28, 1997 5,000 $24.750
SmithKline Beecham Corporation February 28, 1997 2,500 $24.875
_______
335,000

-------------------------

Cheers,
Ed
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext